• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在高侵袭性乳腺癌细胞中,组织因子途径抑制剂-2通过抑制KLF6结合被CpG高甲基化所抑制。

Tissue factor pathway inhibitor-2 was repressed by CpG hypermethylation through inhibition of KLF6 binding in highly invasive breast cancer cells.

作者信息

Guo Hongshen, Lin Yifeng, Zhang Hongwei, Liu Juan, Zhang Nong, Li Yiming, Kong Desheng, Tang Qiqun, Ma Duan

机构信息

Key Laboratory of Molecular Medicine, Ministry of Education, Yixueyuan Road 138#, Shanghai Medical College, Fudan University, Shanghai 200032, China.

出版信息

BMC Mol Biol. 2007 Dec 3;8:110. doi: 10.1186/1471-2199-8-110.

DOI:10.1186/1471-2199-8-110
PMID:18053161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2233638/
Abstract

BACKGROUND

Tissue factor pathway inhibitor-2 (TFPI-2) is a matrix-associated Kunitz inhibitor that inhibits plasmin and trypsin-mediated activation of zymogen matrix metalloproteinases involved in tumor progression, invasion and metastasis. Here, we have investigated the mechanism of DNA methylation on the repression of TFPI-2 in breast cancer cell lines.

RESULTS

We found that both protein and mRNA of TFPI-2 could not be detected in highly invasive breast cancer cell line MDA-MB-435. To further investigate the mechanism of TFPI-2 repression in breast cancer cells, 1.5 Kb TFPI-2 promoter was cloned, and several genetic variations were detected, but the promoter luciferase activities were not affected by the point mutation in the promoter region and the phenomena was further supported by deleted mutation. Scan mutation and informatics analysis identified a potential KLF6 binding site in TFPI-2 promoter. It was revealed, by bisulfite modified sequence, that the CpG island in TFPI-2 promoter region was hypermethylated in MDA-MB-435. Finally, using EMSA and ChIP assay, we demonstrated that the CpG methylation in the binding site of KLF-6 diminished the binding of KLF6 to TFPI-2 promoter.

CONCLUSION

In this study, we found that the CpG islands in TFPI-2 promoter was hypermethylated in highly invasive breast cancer cell line, and DNA methylation in the entire promoter region caused TFPI-2 repression by inducing inactive chromatin structure and decreasing KLF6 binding to its DNA binding sequence.

摘要

背景

组织因子途径抑制剂-2(TFPI-2)是一种与基质相关的库尼茨抑制剂,可抑制纤溶酶和胰蛋白酶介导的参与肿瘤进展、侵袭和转移的酶原基质金属蛋白酶的激活。在此,我们研究了乳腺癌细胞系中DNA甲基化对TFPI-2抑制的机制。

结果

我们发现,在高侵袭性乳腺癌细胞系MDA-MB-435中无法检测到TFPI-2的蛋白质和mRNA。为了进一步研究乳腺癌细胞中TFPI-2抑制的机制,克隆了1.5 kb的TFPI-2启动子,并检测到几个基因变异,但启动子荧光素酶活性不受启动子区域点突变的影响,缺失突变进一步支持了这一现象。扫描突变和信息学分析确定了TFPI-2启动子中一个潜在的KLF6结合位点。亚硫酸氢盐修饰序列显示,MDA-MB-435中TFPI-2启动子区域的CpG岛高度甲基化。最后,通过电泳迁移率变动分析(EMSA)和染色质免疫沉淀分析(ChIP),我们证明KLF-6结合位点的CpG甲基化减少了KLF6与TFPI-2启动子的结合。

结论

在本研究中,我们发现高侵袭性乳腺癌细胞系中TFPI-2启动子的CpG岛高度甲基化,整个启动子区域的DNA甲基化通过诱导无活性的染色质结构和减少KLF6与其DNA结合序列的结合导致TFPI-2抑制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7692/2233638/ef9db3894ad0/1471-2199-8-110-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7692/2233638/e0f31637c007/1471-2199-8-110-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7692/2233638/9c4e15be6f87/1471-2199-8-110-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7692/2233638/1265009ad95d/1471-2199-8-110-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7692/2233638/97097274a561/1471-2199-8-110-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7692/2233638/ef9db3894ad0/1471-2199-8-110-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7692/2233638/e0f31637c007/1471-2199-8-110-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7692/2233638/9c4e15be6f87/1471-2199-8-110-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7692/2233638/1265009ad95d/1471-2199-8-110-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7692/2233638/97097274a561/1471-2199-8-110-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7692/2233638/ef9db3894ad0/1471-2199-8-110-5.jpg

相似文献

1
Tissue factor pathway inhibitor-2 was repressed by CpG hypermethylation through inhibition of KLF6 binding in highly invasive breast cancer cells.在高侵袭性乳腺癌细胞中,组织因子途径抑制剂-2通过抑制KLF6结合被CpG高甲基化所抑制。
BMC Mol Biol. 2007 Dec 3;8:110. doi: 10.1186/1471-2199-8-110.
2
Transcriptional silencing of the TFPI-2 gene by promoter hypermethylation in choriocarcinoma cells.在绒毛膜癌细胞中,启动子高甲基化导致TFPI - 2基因的转录沉默。
Biol Chem. 2003 Jul;384(7):1029-34. doi: 10.1515/BC.2003.115.
3
Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.组织因子途径抑制剂-2(TFPI-2)的启动子甲基化与沉默,TFPI-2是一种在人类胶质瘤细胞中编码基质金属蛋白酶抑制剂的基因。
Oncogene. 2003 Jul 17;22(29):4509-16. doi: 10.1038/sj.onc.1206695.
4
Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.ARHI基因(一种印记肿瘤抑制基因)的异常甲基化和沉默,该基因在乳腺癌中功能丧失。
Cancer Res. 2003 Jul 15;63(14):4174-80.
5
Epigenetic silencing of TFPI-2 in canine diffuse large B-cell lymphoma.TFPI-2 在犬弥散性大 B 细胞淋巴瘤中的表观遗传沉默。
PLoS One. 2014 Apr 2;9(4):e92707. doi: 10.1371/journal.pone.0092707. eCollection 2014.
6
Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer.缺氧对乳腺癌组织因子途径抑制物表达的影响。
J Thromb Haemost. 2016 Feb;14(2):387-96. doi: 10.1111/jth.13206. Epub 2016 Jan 30.
7
Hyper-methylation of the upstream CpG island shore is a likely mechanism of GPER1 silencing in breast cancer cells.上游CpG岛岸的高甲基化是乳腺癌细胞中GPER1沉默的一种可能机制。
Gene. 2017 May 30;614:65-73. doi: 10.1016/j.gene.2017.03.006. Epub 2017 Mar 7.
8
Promoter methylation reduces C/EBPdelta (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors.启动子甲基化降低了SUM-52PE人乳腺癌细胞系和原发性乳腺肿瘤中C/EBPδ(CEBPD)基因的表达。
Breast Cancer Res Treat. 2006 Jan;95(2):161-70. doi: 10.1007/s10549-005-9061-3. Epub 2005 Dec 2.
9
Promoter hypermethylation and silencing of tissue factor pathway inhibitor-2 in oral squamous cell carcinoma.组织因子途径抑制剂-2在口腔鳞状细胞癌中的启动子高甲基化与沉默
J Transl Med. 2014 Sep 2;12:237. doi: 10.1186/s12967-014-0237-7.
10
Epigenetic and HIF-1 regulation of stanniocalcin-2 expression in human cancer cells.人类癌细胞中鲽鱼钙蛋白-2表达的表观遗传与低氧诱导因子-1调控
Exp Cell Res. 2008 May 1;314(8):1823-30. doi: 10.1016/j.yexcr.2008.03.001. Epub 2008 Mar 8.

引用本文的文献

1
Transcriptome Analysis Suggests PKD3 Regulates Proliferative Glucose Metabolism, Calcium Homeostasis and Microtubule Dynamics After MEF Spontaneous Immortalization.转录组分析表明PKD3在小鼠胚胎成纤维细胞自发永生化后调节增殖性葡萄糖代谢、钙稳态和微管动力学。
Int J Mol Sci. 2025 Jan 12;26(2):596. doi: 10.3390/ijms26020596.
2
Restoration of TFPI2 by LSD1 inhibition suppresses tumor progression and potentiates antitumor immunity in breast cancer.抑制 LSD1 恢复 TFPI2 可抑制乳腺癌的肿瘤进展并增强抗肿瘤免疫。
Cancer Lett. 2024 Sep 28;600:217182. doi: 10.1016/j.canlet.2024.217182. Epub 2024 Aug 21.
3
Tissue factor pathway inhibitor-2 (TFPI-2)-an underappreciated partaker in cancer and metastasis.

本文引用的文献

1
Silencing of tissue factor pathway inhibitor-2 gene in malignant melanomas.恶性黑色素瘤中组织因子途径抑制物-2基因的沉默
Int J Cancer. 2007 Jul 15;121(2):301-7. doi: 10.1002/ijc.22637.
2
The Sp family of transcription factors regulates the human laminin alpha1 gene in JAR choriocarcinoma cells.转录因子Sp家族调控JAR绒毛膜癌细胞中的人层粘连蛋白α1基因。
Biochim Biophys Acta. 2006 Nov-Dec;1759(11-12):573-9. doi: 10.1016/j.bbaexp.2006.10.005. Epub 2006 Oct 27.
3
Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells.
组织因子途径抑制剂-2(TFPI-2)——在癌症和转移中被低估的参与者。
Cancer Metastasis Rev. 2024 Dec;43(4):1185-1204. doi: 10.1007/s10555-024-10205-7. Epub 2024 Aug 17.
4
The Tissue Factor Pathway in Cancer: Overview and Role of Heparan Sulfate Proteoglycans.癌症中的组织因子途径:硫酸乙酰肝素蛋白聚糖的概述及作用
Cancers (Basel). 2023 Feb 28;15(5):1524. doi: 10.3390/cancers15051524.
5
Roles of Krüppel-like factor 6 splice variant 1 in the development, diagnosis, and possible treatment strategies for non-small cell lung cancer.Krüppel样因子6剪接变体1在非小细胞肺癌发生、诊断及可能的治疗策略中的作用
Am J Cancer Res. 2022 Oct 15;12(10):4468-4482. eCollection 2022.
6
TFPI2 Promotes Perivascular Migration in an Angiotropism Model of Melanoma.TFPI2在黑色素瘤的向血管性模型中促进血管周围迁移。
Front Oncol. 2021 Jun 24;11:662434. doi: 10.3389/fonc.2021.662434. eCollection 2021.
7
Tissue factor pathway inhibitor‑2 is specifically expressed in ovarian clear cell carcinoma tissues in the nucleus, cytoplasm and extracellular matrix.组织因子途径抑制剂-2 在卵巢透明细胞癌组织中特异性表达于细胞核、细胞质和细胞外基质。
Oncol Rep. 2021 Mar;45(3):1023-1032. doi: 10.3892/or.2021.7944. Epub 2021 Jan 20.
8
LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15.LncRNA LUCAT1/miR-181a-5p 轴通过靶向 KLF6 和 KLF15 促进乳腺癌的增殖和侵袭。
BMC Mol Cell Biol. 2020 Sep 30;21(1):69. doi: 10.1186/s12860-020-00310-0.
9
TFPI2 suppresses breast cancer progression through inhibiting TWIST-integrin α5 pathway.TFPI2 通过抑制 TWIST-整合素 α5 通路抑制乳腺癌进展。
Mol Med. 2020 Apr 5;26(1):27. doi: 10.1186/s10020-020-00158-2.
10
Indirect regulation of TFPI-2 expression by miR-494 in breast cancer cells.miR-494 对乳腺癌细胞 TFPI-2 表达的间接调控。
Sci Rep. 2020 Mar 4;10(1):4036. doi: 10.1038/s41598-020-61018-x.
组织因子途径抑制剂-2由血管内皮生长因子上调,并抑制生长因子诱导的内皮细胞增殖。
Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2819-25. doi: 10.1161/01.ATV.0000248731.55781.87. Epub 2006 Oct 5.
4
Activation of the human pregnancy-specific glycoprotein PSG-5 promoter by KLF4 and Sp1.KLF4和Sp1对人妊娠特异性糖蛋白PSG-5启动子的激活作用。
Biochem Biophys Res Commun. 2006 May 12;343(3):745-53. doi: 10.1016/j.bbrc.2006.03.032. Epub 2006 Mar 20.
5
Analysis of sequence variations in the promoter region of the human tissue factor pathway inhibitor 2 gene in apoplectic patients and blood donors.中风患者和献血者中人类组织因子途径抑制物2基因启动子区域序列变异的分析。
Ann Hematol. 2006 Jan;85(1):32-7. doi: 10.1007/s00277-005-0023-y. Epub 2005 Oct 25.
6
Recombinant adeno-associated virus (rAAV) expressing TFPI-2 inhibits invasion, angiogenesis and tumor growth in a human glioblastoma cell line.表达组织因子途径抑制物-2(TFPI-2)的重组腺相关病毒(rAAV)可抑制人胶质母细胞瘤细胞系的侵袭、血管生成和肿瘤生长。
Int J Cancer. 2005 Jul 20;115(6):998-1005. doi: 10.1002/ijc.20965.
7
Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer.组织因子途径抑制物-2基因在非小细胞肺癌中的表达及甲基化状态
Br J Cancer. 2005 Feb 28;92(4):775-83. doi: 10.1038/sj.bjc.6602298.
8
Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma.TFPI-2的表观遗传失活是与胰腺导管腺癌生长和侵袭相关的常见机制。
Oncogene. 2005 Jan 27;24(5):850-8. doi: 10.1038/sj.onc.1208050.
9
Expression and characterization of the first kunitz domain of human tissue factor pathway inhibitor-2.
Biochem Biophys Res Commun. 2004 Nov 26;324(4):1179-85. doi: 10.1016/j.bbrc.2004.09.179.
10
Genetic variations in the human TFPI-2 gene and its promoter region by denaturing high performance liquid chromatography.采用变性高效液相色谱法分析人TFPI-2基因及其启动子区域的遗传变异。
Thromb Res. 2004;113(5):341-3. doi: 10.1016/j.thromres.2004.03.019.